CLEC4A and chronic obstructive pulmonary disease: Employing appropriate animal models that represent chronic diseases driven by neutrophils and monocytes/macrophages-mediated pathology, such as COPD and neutrophilic asthma, would yield more informative results for examining the therapeutic effects of targeting DCIR.